USGIU
LABD icon

U.S. Global Investors (USGI)’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

U.S. Global Investors (USGI)’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2
Closed -$57K – 161
2016
Q4 		$57K Buy
+2
New +$76.9K 0.02% 141

Other funds holding LABD

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

U.S. Global Investors (USGI)'s LABD Position: Q1 2017 in Review

U.S. Global Investors (USGI) sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2017, closing a stake of 2 shares — an estimated $57K sold.

U.S. Global Investors (USGI) first reported a position in LABD in Q4 2016 and held it in 1 quarter. The position peaked at $57K in Q4 2016. 13 funds tracked by Wall St. Rank hold LABD as of Q1 2017.

  • U.S. Global Investors (USGI) reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2017 after selling out during the quarter.
  • U.S. Global Investors (USGI) sold 2 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2017, an estimated $57K.
  • U.S. Global Investors (USGI) first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2016 and held it in 1 quarter.
  • U.S. Global Investors (USGI)'s Direxion Daily S&P Biotech Bear 3X ETF position peaked at $57K in Q4 2016.
  • 13 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2017.

Based on U.S. Global Investors (USGI)'s 13F filing for Q1 2017, filed 12 May 2017.